Medicinal and aromatic plants exhibit important pharmacological activities to human. The present study evaluates the diuretic activity of aqueous extract of Merremia emarginata (MEAE).
Methods
Female Wistar albino rats were used for diuretic activity in vivo studies. Urinary hippuric acid of treated animal group was successfully quantified by RP-HPLC. UPLC-MS/MS is used for the identification of important bioactive compound in MEAE.
Results
Diuretic activity was confirmed through analyzing the disparity in total volume and diuretic markers (total sodium and potassium concentration of urine) which was compared to normal group rats. MEAE plays a crucial role for inducing diuretics without side effects such as glycosuria or proteinuria. This activity was significantly high (p < 0.05) compared to control group rats and diuretic responsible polyphenolic compound chlorogenic acid was identified in MEAE through RP-HPLC and UPLC-MS/MS.
Conclusion
Hippuric acid is a byproduct of chlorogenic acid and reported to be responsible for inducing diuretics. Secondary metabolites such as chlorogenic acid and their byproducts might be responsible for diuretic activity. Hippuric acid can act as a diuretic agent as well as it could be used as a biomarker to detect the polyphenolics induced diuretic activity. M. emarginata can act as an excellent diuretic agent, without causing any harmful side effects.
Abkürzungen
CA inhibitors
Carbonic anhydrase inhibitors
CPCSEA
Control and supervision of experiments on animals
ESI
Electron Spray Ionization
MEAE
M. emarginata aqueous extract
PDA
Photo Diode Array
RP-HPLC
Reverse Phase High Performance Liquid Chromatography
UPLC-MS
Ultra Performance Liquid Chromatography
USA
United States of America
λ max
Maximum Absorbance
Background
Merremia emarginata (Burm. f.) belongs to family Convolvulaceae is prevalent throughout India and tropical region of Asia. This plant is uncultivated food crop used by people in India as green leaf vegetable and creeping perennial herb rooting at the nodes. M. emarginata traditionally used as diuretic, deobstruent, rheumatism, neuralgia, cough and headache [1]. Previous reports suggested that M. emarginata leaves have strong antioxidant property and antibacterial activity against both gram positive and gram negative bacterial [2, 3].
A diuretic drug is any substance that elevates the urine excretion, they are widely used for treatment of edema, congestive heart failure, hypertension, liver and kidney diseases [4]. Now a day’s many commercial diuretic drugs available in the market are class of thiazide (chlorothiazide, hydrochlorothiazide etc), loop (furosemide, bumetanide etc), K+ sparing (amioloride, eplerenone etc) and CA inhibitors (acetazolamide, dichlorphenamideetc). These commercial diuretics drugs have variety of side effects such as hypokalemia, metabolic alkalosis, dehydration (hypovolemia), leading to hypotension, fever, cough, unusual bleeding, excessive weight loss, nausea, vomiting [5]. Diuretic drugs of medicinal plants origin are a better alternative to commercial diuretic drugs. Wright et al. [6] reported that about hundreds of medicinal plants and its extracts were successfully investigated for their diuretic property. The most successful and most potential diuretic medicinal plant genus includes Spergularia purpurea, Petroselinum sativum, Foeniculum vulgare and Hibiscus sabdariffa [7‐10]. These medicinal plants contain secondary metabolites (alkaloids, phenolics and flavonoids etc.) which might be responsible for diuretic activity [11, 12]. But there is no previous report about specific phenolic compound and its byproduct for diuretic activity. The mechanism of medicinal plant induces diuretic activity is still unclear. Further, Kaur, [13] reported that, cow urine containing hippuric acid responsible for induced diuretic activity. Based on this, the present study was carried out to study the diuretic activity of MEAE. Chlorogenic acid which is one of the phenolic compounds found in MEAE and hippuric acid is a byproduct of chlorogenic acid was detected in our plant extract treated rat urine sample through RP-HPLC which indirectly reveals about the role of polyphenolics present in the plant extract in inducing diuretics.
Anzeige
Methods
Plant collection
Fresh leaves of M. emarginata were collected from Dharmapuri, Tamil Nadu in India. The identity of the plant was authenticated by the Department of Plant Science, Bharathidasan University, Tiruchirappalli. The leaves were picked and washed with distilled water to remove all the unwanted debris and shade dried under room temperature of 30 °C for 10 days, ground into powder using electronic grinder and stored in an airtight container until further use.
Preparation aqueous extract
Ten gram of powdered plant material was extracted with distilled water (250 ml; 27–30 °C) on shaker (Orbitec-scigenics Biotech, India) for 48 h. The extract was filtered and quickly frozen at − 80 °C and dried for 48 h using a vacuum freeze dryer (Christ alpha 1–2 / LD plus, Germany) to give a yield of 8.87% of dry extract. The resulting extract was reconstituted with distilled water to give desired concentrations and used for further analysis.
In vivo studies
Adult female Wistar albino rats weighing 150–200 g were housed in standard cages with good feed and water access. Experimental procedures and protocols were approved by the committee (BDU/IAEC/2012/33/28/03/2012) for the purpose of CPCSEA, Chennai, Tamil Nadu, India.
Experimental method
Diuretic activity was carried out by Biswas et al. [14] method. Animals were divided into five groups each with five rats. Before starting the experiment, the rats were starved for 18 h. Among the five groups, group one served as a control which was fed normal drinking water only (10 ml/kg b.w.). Second group served as a commercial diuretic drug treated (furosemide 20 mg/kg b.w.). The third, fourth and fifth groups received MEAE orally at the doses of 200, 400 and 600 mg/kg b.w. respectively. After administration of drugs (orally), animals were caged immediately under sterile condition. Urine samples were collected up to 5 h, during the experiment, food and water was not given to the animals in cages. After collection, urine samples were preserved with sodium azide to avoid microbial contamination. Further, urine Na+ and K+ ions were analyzed by flame photometer (Elico. CL 378, India) [15]. Total protein was estimated by Bradford standard protocol [16] and glucose was analyzed through Ortho tolludine method [17].
Anzeige
Identification and quantification of hippuric acid through RP-HPLC
Rat urine was centrifuged at 13000 rpm for 4 min at 4 °C. The resulting supernatant was used for further analysis. The RP-HPLC on a C18 column (4.6 × 250 mm, 5 μm particle size) was used for hippuric acid identification. Analytical HPLC system employed consists of Waters high performance liquid chromatography coupled with a photodiode array detector (PDA-2998), USA. Mobile phase consist of water with 0.1% formic acid (Solvent A) and 100% methanol (Solvent B), the gradient program followed; Solvent A and B was 0–10% (5 min), 10–15% (5 min), 15–20% (5 min), 20–30% (5 min), 30–40% (10 min); Flow rate was 1 ml/min. Detection was carried out in the multi wavelength detection range of 210 to 400 [18]. Hippuric acid presence in urine sample was confirmed by comparing its retention time and λ max of an authentic standard.
Chlorogenic acid identification by UPLC-MS/MS
UPLC was carried out using Waters UPLC system with PDA detector by Waters Corporation, USA. C18 UPLC column (150 mm X 2.1 mm dia X 1.7 μm particle size) used for chlorogenic acid identification. The mobile phase was similar as followed in RP-HPLC analysis. Gradient program was optimized according to UPLC condition. Mass Spectrometric analysis of phenolic compounds carried out by SYNAPT Mass Spectrometer from Waters, USA with ESI mode. Compounds were analyzed both positive and negative modes.
Statistical analysis
All the statistical data were analyzed through SPSS 16.0 and Origin 6.0. The significance of difference between the groups was determined using one way ANOVA. All data were expressed as mean ± standard deviation (SD). The significance level was expresses as p < 0.05.
Results and discussion
Diuretic and excretion parameters analysis
The volume of urine measured up to 5 h. Table 1 shows total volume of urine excretion, total sodium, total potassium, total protein and total glucose concentration in the rat urine samples. Total volume of urine excretion data shows (MEAE) and furosemide (Lasix) treated rat group excreted high volume of urine compared to untreated control group. MEAE treated rat groups urine excretion had increased in a dose dependant manner. Furosemide (20 mg/kg b.w) treated animal group urine volume (3.55 ± 0.03 ml/5 h) is very high when compared to 600 mg/kg b.w MEAE treated group, (2.61 ± 0.05 ml/5 h), volume of urine at when the total sodium and potassium levels were significantly increased (p < 0.05) in the treated animal group when compared to control group. Total protein and glucose levels in urine samples of MEAE treated animal groups were similar to control group. These results clearly indicate that the plant doesn’t produce side effects such as either proteinuria or glycosuria.
Table 1
Effect of MEAE on diuretic excretion parameters of albino Wistar rat urine
Treatment Groups
Total volume of Urine (ml/5 h)
Total Sodium (mEq/l)
Total Potassium (mEq/l)
Total Protein (μmol/dl)
Total Glucose (mg/dl)
Control
1.55 ± 0.03d
120.3 ± 1.2e
210.6 ± 1.1e
1.162 ± 0.1c
2.3 ± 0.5d
Furosemide (20 mg/kg b.w.)
3.58 ± 0.08a
225.7 ± 1.9d
365.1 ± 1.8a
1.249 ± 0.02a
6.3 ± 0.07a
MEAE (200 mg/kg b.w.)
1.46 ± 0.02e
309.1 ± 2.2c
243.1 ± 1.5d
0.667 ± 0.01e
3.4 ± 0.12c,b
MEAE (400 mg/kg b.w.)
1.83 ± 0.04c
325.3 ± 1.8b
289.4 ± 2.1c
0.817 ± 0.01d
3.5 ± 0.07c,a
MEAE (600 mg/kg b.w.)
2.61 ± 0.05b
345.1 ± 1.3a
349.4 ± 1.7b
1.218 ± 0.01b
4.1 ± 0.04b
Mean ± SD obtained from analysis of three independent samples, in duplicate
abcde; In each column, the superscript letters significantly differences in the mean at (P < 0.05) level
Identification of chlorogenic acid through RP-HPLC and UPLC-MS/MS
Occurrence of chlorogenic acid in the MEAE was confirmed by comparing with chlorogenic acid standard (HPLC grade, Sigma) retention time, absorbance spectrum and mass analysis through MS/MS fragmentation (Fig. 1a and b). The presence of chlorogenic acid in MEAE was detected through UPLC-MS/MS and confirmed by MS/MS fragmentation pattern in both positive [M-H]+ and negative [M - H]ˉ mode ionization. The chlorogenic acid exact molar mass is 354.09. Fig. 1a shows chlorogenic acid in [M-H]+ mode, the mass of base peak gave [M-H]+ ion at m/z is 355.21, and MS2 fragmentation [M-H]+ ion shows at 163.07. In negative [M - H]ˉ ion mode (Fig. 1b), chlorogenic acid shows a base peak at 353.09, and MS2 fragmentation [M-H]− ion shows at 191.26, 173.18 and 135.13 respectively. It was same fragmentation pattern previously reported [19, 20].
Fig. 1
UPLC-MS/MS analysis shows chlorogenic acid fragmentation pattern in both positive and negative ion mode (1a. Positive [M - H]+, 1b. Negative [M - H]ˉ ion mode)
×
Detection and quantification of hippuric acid through RP-HPLC analysis
Gonthier et al. [21] studied about chlorogenic acid degradation through gut microbial pathway. Their result shows the chlorogenic acid degradation or digestion through gut microorganisms, from this microbial degradation, chlorogenic acid produced byproducts namely hippuric acid and 3- hydroxyhippuric acid. This hippuric acid can act as diuretic agent [13], but the mechanism of hippuric acid acting as diuretics is still unclear.
The filtered urine sample was injected into RP-HPLC to determine the hippuric acid content. The presence of hippuric acid in the urine was confirmed by comparing the peak with retention time and absorbance spectrum of commercial hippuric acid standard. The absorbance maximum at 265.5 nm and retention time of 3.449 ± 0.1 min was observed in both commercial hippuric acid standard and urine sample (Fig. 2a and b). Hippuric acid content of the urine samples (control and drug treated) were determined based on the hippuric acid standard curve (y = 5342.x – 35,193, R2= 0.999). Hippuric acid content of control and furosemide treated was 97.25 and 566.3 ng/ml respectively. MEAE treated (200, 400 and 600 mg/kg b.w) groups showed hippuric acid content 240.8, 494.9 and 620.7 ng/ml respectively (Table 2). Control and furosemide treated excretion of hippuric acid perhaps due to benzoic acid conjugated hippuric acid excretion [22], because generally hippuric acid is the glycine conjugate of benzoic acid. Because, hippuric acid synthesized in the liver and its production is greatly increased from benzoic acid based food substance or substances which generate benzoic acid during intermediate metabolism (e.g. polyphenols such as chlorogenic acid, quinic acid and caffeic acid) [20, 21]. Perhaps, based on the polyphenolic concentration, the hippuric acid elution was increased in the MEAE treated group urine sample, the hippuric acid excretion in the urine got increased with increase in MEAE dose in a dose depended manner. The commercial drug furosemide chemical name is (4-Chloro-N-furfuryl-5-sulfamoylanthranilic acid 5-(Aminosulfonyl)-4-chloro-2-([2 furanylmethyl] amino) benzoic acid) and the furosemide functional group benzoic acid conjugated with glycine may induce diuretics through hippuric acid formation, but that mechanism is still unclear.
Fig. 2
a RP-HPLC chromatograms (photo-diode array detector set at 200–400 nm). Hippuric acid (HA) standard maximum absorption (λ max) is at 265.5 nm and Retention time is 3.4 min. b RP-HPLC chromatograms (PDA detector set at 200–500 nm). Hippuric acid (HA) analysis from MEAE treated albino Wistar rat urine sample. Maximum absorption (λ max) is at 265.5 nm and Retention time is at 3.5 min
Table 2
Effect of MEAE on hippuric acid concentration in urine samples collected from MEAE treated rats
Treatment Groups
Hippuric Acid (ng/ml)
Control
97.25 ± 1.0e
Furosemide (20 mg/kg b.w.)
566.3 ± 5.87b
MEAE (200 mg/kg b.w.)
240.8 ± 4.04d
MEAE (400 mg/kg b.w.)
494.9 ± 3.51c
MEAE (600 mg/kg b.w.)
620.7 ± 8.38a
Mean ± SD obtained from analysis of three independent samples, in duplicate
abcde; in column, the superscript letters significantly differences in the mean at (P < 0.05) level
×
On the other hand, secondary metabolites profile of MEAE by UPLC-MS/MS shows the presence of chlorogenic acid. Chlorogenic acid is well known plant secondary metabolite, which is responsible for inducing diuretic activity [23]. Similarly, plant secondary metabolites altered the diuretic markers like sodium, potassium and chloride levels in human urine [24, 25]. From these results, the total volume of urine, sodium and potassium levels clearly indicate that the plant M. emarginata play crucial role for inducing diuretic activity. The presence of chlorogenic acid has been confirmed through RP-HPLC and UPLC-MS/MS and it might be responsible for inducing diuretics in animal model.
Anzeige
Conclusion
Based on the results we conclude that the M. emarginata can act as a good diuretic agent, without causing any side effects such as proteinuria or glycosuria. M. emarginata secondary metabolites may act as diuretic agents, especially chlorogenic acid and their byproducts. Chlorogenic acid byproduct, hippuric acid can act as a diuretic agent as well as it could be used as a biomarker to detect the polyphenolics induced diuretic activity. However, the mechanism of chlorogenic acid inducing diuretics is unclear. Furthermore, additional studies need to be carried out to purify the bioactive compounds to evaluate diuretic activity and hippuric acid excretion analysis using animal as model system.
Acknowledgements
A.R thanks University Grants Commission (UGC), India for UGC Research Fellowship in Science for Meritorious students under Non-SAP programme and Bharathidasan University for providing University research scholar fellowship. Authors sincerely thank Department of Science and Technology (DST-FIST) and UGC-SAP, India for providing instrumental facilities to our department.
Ethics approval and consent to participate
Experimental procedures and protocols were approved by the committee (BDU/IAEC/2012/33/28/03/2012) for the purpose of Control and supervision of experiments on animals, Chennai, Tamil Nadu, India.
Consent for publication
Not applicable.
Anzeige
Competing interests
The authors declare that they have no competing interests.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
